Skip to content

Interest Paid at other companies

United Therapeutics logo
United TherapeuticsUTHR
$1.9M-64.8%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$1.12M+150%
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$23.42M+226%
NovoCure logo
NovoCureNVCR
$4.96M+87.6%
Nuvation Bio logo
Nuvation BioNUVB
$720.5K+745%
Celcuity logo
CelcuityCELC
$5.89M+147%

Other financials

Income statement

See full
Revenue-
Operating income-$11.4M+27.5%
Net income-$10.8M+27.5%
EPS (diluted)-$0.11+35.3%

Balance sheet

See full
Cash & equivalents$10.0M-3.4%
Total debt$12.3M-9.2%
Total equity$57.9M-22.8%
Total assets$79.7M-18.1%

Cash flow

See full
Operating cash flow-$12.5M+18.8%
CapEx$138.0K
Free cash flow-$12.7M+17.9%

Valuation

See full
Market cap$1.14B+20.6%
Enterprise value$1.14B
P/S6,001×

Profitability

See full
Operating margin-40,856.3%+28,833pp
Net margin-39,009.5%+29,653pp
FCF margin-32,664.7%+4,018pp

Returns & leverage

See full
Return on equity-105.3%+50.6pp
Debt / equity0.2×0.0×
Current ratio5.8×-2.0×

Where this comes from

Reported directly by Ethos Technologies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestPaidNet.

The official record: Ethos Technologies, Inc. ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ethos Technologies, Inc. 's interest paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ethos Technologies, Inc. 's interest paid?
Ethos Technologies, Inc. (LIFE) reported interest paid of $17K in Q1 2026.
How has Ethos Technologies, Inc. 's interest paid changed year-over-year?
Ethos Technologies, Inc. 's interest paid decreased by 39.3% year-over-year, from $28K to $17K.
What does interest paid mean?
Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.